A recent article highlighting the prevalence of substandard and falsified medicines in Africa, including Malawi, has been disputed by a leading expert in the field.
Advertisement
Sign up for Nthanda Times
Top Stories Newsletter
Politics, education, health, and more—get the latest news that matters most to you.
protected by reCAPTCHA
Advertisement
A former professor at the University of Malawi’s Pharmacy Department, Professor Dr. Lutz Heide, has challenged the accuracy of the report, citing outdated and flawed methodology.
In a news article on guardian online https://www.theguardian.com/world/article/2024/aug/04/fifth-of-medicines-africa-substandard-fake-research one-fifth of medicines in Africa, including Malawi, may be substandard or fake, posing a significant threat to public health, according to a recent research study.
Advertisement
The article reported that Malawi has the highest proportion of substandard and falsified medicines, highlighting a critical issue that demands immediate attention.
The study, conducted by Bahir Dar University in Ethiopia, analysed 27 studies and found that 1,639 out of 7,508 medicine samples failed quality tests.
However, Prof. Heide’s research group and others say they have conducted subsequent studies demonstrating better medicine quality in Malawi compared to many African countries.
Advertisement
Heide: We have published several studies showing that medicine quality in Malawi is actually better
“We have published several studies showing that medicine quality in Malawi is actually better than in many other African countries. Only the incorrect, outdated information may unsettle patients and prevent them from seeking life-saving treatment.” Prof. Heide stated.
Heide’s research, published in reputable scientific journals, contradicts the initial findings.
His studies indicate improved medicine quality in Malawi, contrary to the report’s claims.
In an interview with Malawi News Agency (MANA), the Pharmacy and Medicines Regulatory Authority (PMRA) Public Relations Officer Joseph Josiah say they have taken note of the concerns in the article published by The Guardian Newspaper and the board is re-examining the methodology used in the 2015 study.
Advertisement
The Guardian Report questions the efficacy of medicines in Malawi
The review, which analysed studies published between 2014 and 2024 from different countries in Africa, referenced a 2015 study by a Malawian researcher at the University of Ghana and in his study he reported that Malawi had 88.4% prevalence of poor-quality medicines.
Josiah said PMRA is currently re-examining the methodology used in this 2015 study, as it is the primary source informing the review’s findings which have singled out Malawi as among the countries with highest proportion of the said substandard and falsified medicines as reported by The Guardian newspaper.
“We are taking this step to ensure the accuracy and reliability of the data, as the PMRA is committed to safeguarding public health and maintaining the integrity of the pharmaceutical supply chain in Malawi.
We take these findings seriously and are committed to ensuring the quality and safety of medicines in Malawi,” Josiah said.
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.